Janux Therapeutics (JANX) Return on Sales (2021 - 2026)
Janux Therapeutics (JANX) posted quarterly Return on Sales of 0.14% for Q1 2026, up 73.0% year-over-year from 0.08% in Q1 2025, and up 68.55% quarter-over-quarter from 0.45% in Q4 2025.
Janux Therapeutics (JANX) Return on Sales (2021 - 2026) Analysis & Trends
Janux Therapeutics (JANX) has reported Return on Sales for 6 consecutive years, with 0.14% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Sales rose 73.0% year-over-year to 0.14%; the TTM figure through Mar 2026 stood at 0.25% (up 61.0% YoY), while the FY2025 annual figure was 0.14%, up 26.0% from the prior year.
- Return on Sales rose to 0.14% in Q1 2026 per JANX's latest filing, from 0.45% in the prior quarter.
- Across five years, Return on Sales topped out at 0.05% in Q4 2023 and bottomed at 14.78% in Q2 2025.
- Historically, Return on Sales has averaged 1.73% across 5 years, with a median of 0.3% in 2022.
- On a YoY basis, Return on Sales climbed as much as 765 bps in 2025 and fell as far as 1445 bps in 2025.
- Janux Therapeutics' Return on Sales stood at 0.06% in 2022, then rose by 17 bps to 0.05% in 2023, then plunged by 1725 bps to 0.87% in 2024, then jumped by 48 bps to 0.45% in 2025, then surged by 69 bps to 0.14% in 2026.
- Business Quant data shows JANX's Return on Sales at 0.14% in Q1 2026, 0.45% in Q4 2025, and 0.13% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 0.00% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Janux Therapeutics | 984.58 Mn | 984.58 Mn | - | -0.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.06% |
| Mar 31, 2026 | -0.14% |
| Dec 31, 2025 | -0.45% |
| Sep 30, 2025 | -0.13% |
| Jun 30, 2025 | -14.78% |
| Mar 31, 2025 | -0.87% |
| Dec 31, 2024 | -0.87% |
| Sep 30, 2024 | -7.78% |
| Jun 30, 2024 | -0.33% |
| Mar 31, 2024 | -2.14% |
| Dec 31, 2023 | -0.05% |
| Sep 30, 2023 | -0.11% |
| Jun 30, 2023 | -0.51% |
| Mar 31, 2023 | -0.27% |
| Dec 31, 2022 | -0.06% |
| Sep 30, 2022 | -0.30% |
| Jun 30, 2022 | -0.23% |
| Mar 31, 2022 | -0.30% |
| Dec 31, 2021 | -0.08% |
| Sep 30, 2021 | -0.72% |